In Brief: Upcoming NDAC meetings
This article was originally published in The Tan Sheet
Executive Summary
Upcoming NDAC meetings: FDA's Nonprescription Drugs Advisory Committee is tentatively set to meet with the Endocrinologic & Metabolic Drugs Advisory Committee on Sept. 27; with the Drug Abuse Advisory Committee on Sept. 28; and with the Gastrointestinal Drugs Advisory Committee on Sept. 29. The session with the Drug Abuse committee is expected to address smoking cessation aids, an area in which SmithKline Beecham's Nicorette nicotine gum Rx-to-OTC switch application is pending...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning